We are live on ! Find out more
SWTX

SpringWorks Therapeutics

Delisted

SWTX was delisted on the 30th of June, 2025.

137 hedge funds and large institutions have $3.23B invested in SpringWorks Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

11% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 46

10% more funds holding

Funds holding: 124137 (+13)

3% more capital invested

Capital invested by funds: $3.13B → $3.23B (+$103M)

0.72% more ownership

Funds ownership: 88.96%89.68% (+0.72%)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
137
Holders Change
+13
Holders Change %
+10.48%
% of All Funds
2.41%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
25
Increased
51
Reduced
46
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Carson Wealth (CWM LLC)
51
Carson Wealth (CWM LLC)
Nebraska
$4.45M
Citigroup
52
Citigroup
New York
$4.17M +$3.42M +43,690 +336%
Two Sigma Investments
53
Two Sigma Investments
New York
$4.05M +$1.85M +23,653 +75%
Allianz Asset Management
54
Allianz Asset Management
Germany
$4.03M +$3.59M +45,789 +507%
Voloridge Investment Management
55
Voloridge Investment Management
Florida
$3.81M +$3.12M +39,800 +333%
UBS Group
56
UBS Group
Switzerland
$3.39M +$3.45M +44,091 +2,186%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$3.29M -$709K -9,048 -17%
Swiss National Bank
58
Swiss National Bank
Switzerland
$3.28M +$110K +1,400 +3%
Ensign Peak Advisors
59
Ensign Peak Advisors
Utah
$3.25M +$1.43M +18,200 +70%
Rafferty Asset Management
60
Rafferty Asset Management
New York
$3.12M +$2.6M +33,209 +360%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$2.67M -$8.54K -109 -0.3%
N
62
Natixis
France
$2.63M -$2.4M -30,600 -46%
Federated Hermes
63
Federated Hermes
Pennsylvania
$2.58M -$2.15M -27,440 -44%
MIM
64
Monashee Investment Management
Massachusetts
$2.58M +$2.74M +35,000 New
AllianceBernstein
65
AllianceBernstein
Tennessee
$2.52M +$47K +600 +2%
State of Wisconsin Investment Board
66
State of Wisconsin Investment Board
Wisconsin
$2.38M -$78.3K -1,000 -3%
PPA
67
Parametric Portfolio Associates
Washington
$2.04M +$66.3K +846 +3%
CSS
68
Cubist Systematic Strategies
Connecticut
$2M +$1.15M +14,700 +118%
AAA
69
Affinity Asset Advisors
New York
$1.99M +$2.11M +27,000 New
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$1.92M -$139K -1,775 -6%
Balyasny Asset Management
71
Balyasny Asset Management
Illinois
$1.66M +$1.76M +22,492 New
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$1.65M +$117K +1,500 +7%
TD Asset Management
73
TD Asset Management
Ontario, Canada
$1.58M +$155K +1,980 +10%
AI
74
Atom Investors
Texas
$1.5M -$1.85M -23,681 -54%
UBS AM
75
UBS AM
Illinois
$1.43M +$298K +3,800 +24%

SWTX Hedge Fund Activity: Q1 2021 in Review

137 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q1 2021, worth a combined $3.23B — up 3.3% from $3.13B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SWTX positions and 12 closed out — a net gain of 13 holders — while 51 added to existing stakes and 46 trimmed.

The largest buyer was Vanguard Group, adding an estimated $95.8M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $114M.

  • 137 institutional investors held SpringWorks Therapeutics (SWTX) as of Q1 2021, up from 124 in Q4 2020.
  • Funds reported $3.23B of SpringWorks Therapeutics stock for Q1 2021, up 3.3% quarter-over-quarter.
  • 25 funds opened new SpringWorks Therapeutics positions in Q1 2021 and 12 closed out, a net change of +13 holders.
  • The largest SpringWorks Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $95.8M added.
  • The largest SpringWorks Therapeutics seller in Q1 2021 was Bain Capital Life Sciences Investors, an estimated $114M sold.

Based on aggregated 13F filings for Q1 2021.